Patient Organizations

Commitment to Patients’ Interests – Collaboration with Patient Organizations

At Bayer Switzerland, we are committed to transparent and ethically responsible collaboration with patient organizations. Our goal is to improve patients’ quality of life and foster dialogue among all stakeholders.

Our Principles of Collaboration

Independence and Integrity: Our collaborations are based on clear contractual agreements that preserve the independence of patient organizations and prevent conflicts of interest.
Transparency: All financial contributions are disclosed in accordance with the Pharmaceutical Collaboration Code to ensure trust and openness.
Shared Goals: We work with patient organizations to better understand patient needs and jointly develop solutions that offer real added value.

Patient organizations carry out meaningful work to voice patients’ concerns, represent their interests in the public arena and raise awareness. By doing so, they offer those affected and the people around them valuable support.

As a research-oriented company, Bayer makes a key contribution to enhancing health care and quality of life by helping prevent, diagnose, alleviate and cure illnesses. At the heart of these efforts are the patients.

Bayer shares the vision of patient organizations to sustainably improve the quality of life for those affected and provide them with swift access to innovative treatment options and health care services.

Our collaboration with patient organizations is transparent and based on our stringent ethical standards, with the organizations retaining their independence and neutrality.

In 2025, Bayer (Schweiz) AG provided support to the following patient organizations:

Patient Organization	Our support
EUPATI Switzerland https://ch.eupati.eu/	CHF 8’000.– for Supporting Membership & Swiss Patient Forum November 2025 The aim of EUPATI Switzerland is to provide patients with access to education and training in order to enable meaningful patient participation in therapeutic innovation.
Krebsliga beider Basel www.klbb.ch	CHF 30'000.– for Meeting Center House of the Cancer League Basel
Retina Suisse www.retina.ch	CHF 50’000.– to educate the public about eye diseases and provide advice and information to those affected and their relatives and friends. Supporting scientific research in the field of ophthalmology.
PROCASI www.procasi.ch	CHF 3'500.– for event at APCCC 2025 Informative event for patients and members of PROCASI patient advocacy groups during APCCC 2025 (Consensus conference on advanced prostate cancer). PROCASI (PROstata Centro di Auto-aiuto della Svizzera Italiana) brings together people with a diagnosis and treatment of prostate cancer.
Verein Amyloidose Schweiz www.amyloidose- schweiz-ch	CHF 24'000.– for patient event, printing of flyers and basic contribution Association Association for educating the public about amyloidosis and providing advice and information to those affected and their relatives. Support for patient events and scientific research in the field of amyloidosis.
Die GIST-Gruppe Schweiz www.gist.ch	CHF 2'000.– for supporting the annual event on April 25, 2025, for patients and family members of the GIST Group.
Espace OSE Thérapies www.ose-therapies.ch	CHF 5'000.– for supporting Project OSE APA (Adapted sports activities, OSE Well-being/APA)
Verein Orale Tumortherapie www.oraletumortherapie.ch	CHF 2'000.– to support the production of informational leaflets aimed at promoting adherence and safety among patients undergoing oral cancer therapy.

Commitment to Patients’ Interests – Collaboration with Patient Organizations

Archive